Bhasin N, Kumar Sharma M, Yadav DN, Kumar Kumawat DM. Diabetes Ketoacidosis Is a Cause of Concern in Sodium-Glucose Co-Transporter-2 Inhibitors Medication: Pharmaceutical Science-Pharmaceutics. Int J Life Sci Pharm Res [Internet]. 2022 Dec. 31 [cited 2026 Feb. 1];13(SP 1):P55-P67. Available from: https://ijlpr.com/index.php/journal/article/view/1549